Key Market Participants - Frost & Sullivan


5 Δεκ 2012 (πριν από 5 χρόνια και 7 μήνες)

252 εμφανίσεις

© Copyright 2002 Frost & Sullivan. All Rights Reserved.

Biotechnology Industry Overview
and Growth Strategy Framework

Forward Integration Creates Opportunity For
Superior Profit Margins

There exists strong evidence that biotechnology companies'
forward integration efforts are justified not only by the potential for
revenue growth, but also by opportunity for high profit margins.

Lab Instrumentation & Products Analyst Team

Frost & Sullivan

© Copyright 2002 Frost & Sullivan. All Rights Reserved.

Frost & Sullivan provides:

Detailed insights into recent developments and trends

Drivers, restraints, challenges, and strategic

Analyst insights on ‘hot topics’ and emerging applications

in the b
iotechnology industry

Market sizing and competitive analysis

Market forecasts and opportunity analysis

Quarterly assessments

user analysis within each report

Key Features

© Copyright 2002 Frost & Sullivan. All Rights Reserved.

Coverage: The United States

Proven methodology encompassing extensive primary and
secondary data and research

Focused information and strategies that cover business and
technology issues

Credible data and analysis highlighting industry dynamics

Winning strategies to help you create precise business plans

What We Offer

© Copyright 2002 Frost & Sullivan. All Rights Reserved.

Current Market Participants

Find out how you compare to the competition

Assess current and future drivers and restraints

Determine and exploit new market share opportunities

New Entrants

Analyze challenges associated with the industry

Calculate time scales for strategy implementation

Position yourself to capitalize on the market’s unmet needs

Investment Community

Analyze long
term strategies of companies

Determine which participants will outperform the competition

Assess attractiveness of investing in the market

Who Will Benefit?

© Copyright 2002 Frost & Sullivan. All Rights Reserved.

Abgenix, Inc.

Acambis Plc.

Actelion Ltd.

Active Biotech AB

Advanced Tissue Sciences, Inc.

AEterna Laboratories, Inc.

Agenix Ltd.

Alexion Pharmaceuticals, Inc.

Amgen, Inc.

Amrad Corp., Ltd.

Anika Therapeutics, Inc.

Avanir Pharmaceuticals

BioCryst Pharmaceuticals, Inc.

Biogen, Inc.

BioMarin Pharmaceutical, Inc.

Bioniche Life Sciences, Inc.

Biosearch Italia SpA

Technology General Corp.

Cambridge Antibody Technology Group

Cangene Corp.

Carrington Laboratories, Inc.

Key Market Participants

Celgene Corp.

Cell Genesys, Inc.

Cephalon, Inc.

Chiron Corp.

Corixa Corp.

Crucell NV

Cytogen Corp.

Dendreon Corp.

Dyax Corp.

Enzo Biochem, Inc.

Enzon, Inc.

Epimmune, Inc.

Essential Therapeutics, Inc.

Genentech, Inc.

Genesis Research and Development
Corp., Ltd.

Genentech, Inc.

Genome Therapeutics Corp.

Genzyme Corp.

Gilead Sciences, Inc.

GTC Biotherapeutics, Inc.

Guilford Pharmaceuticals, Inc.

Haemacure Corp.

© Copyright 2002 Frost & Sullivan. All Rights Reserved.

Human Genome Sciences, Inc.

Icos Corp.

IDEC Pharmaceuticals Corp.

Ilex Oncology, Inc.

ImClone Systems, Inc.

Immunomedics, Inc.

Indevus Pharmaceuticals, Inc.

Inspire Pharmaceuticals, Inc.

Integra LifeSciences Holdings Corp.

InterMune, Inc.

Isis Pharmaceuticals, Inc.

LifeCell Corp.

Ligand Pharmaceuticals, Inc.

Maxygen, Inc.

Medarex, Inc.

MedImmune, Inc.

Millennium Pharmaceuticals, Inc.

Myriad Genetics, Inc.

NaPro BioTherapeutics, Inc.

Neurocrine Biosciences, Inc.

Nexell Therapeutics, Inc.

Novavax, Inc.

Novogen Ltd.

Key Market Participants (cont’d)

NPS Pharmaceuticals, Inc.

Onyx Pharmaceuticals, Inc.

Organogenesis, Inc.

OSI Pharmaceuticals, Inc.

Oxford GlycoSciences Plc.

Oxigene, Inc.

Peptech Ltd.

Pharming Group NV

Polydex Pharmaceuticals Ltd.

Praecis Pharmaceuticals, Inc.

Progenics Pharmaceuticals, Inc.

Protein Design Labs, Inc.

Regeneron Pharmaceuticals, Inc.

Ribozyme Pharmaceuticals, Inc.

SangStat Medical Corp.

SciClone Pharmaceuticals, Inc.

Scios, Inc.

Senetek Plc.

Targeted Genetics Corp.

Texas Biotechnology Corp.

The Immune Response Corp.

Trimeris, Inc.

Tularik, Inc.

© Copyright 2002 Frost & Sullivan. All Rights Reserved.

Vernalis Group Plc.

Vertex Pharmaceuticals, Inc.

Vical, Inc.

Vitrolife AB

Xoma Ltd.

ZymoGenetics, Inc.

Key Market Participants (cont’d)

© Copyright 2002 Frost & Sullivan. All Rights Reserved.

Call toll free




Fax toll free




For More Information